Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 17 studiesSortNewest indexed ▾
B
grade
Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15.
IGF-1 LR3 (Long R3 IGF-1) · The Journal of clinical endocrinology and metabolism · 1995 · ObservationalHigh-impact journal
Receptor expression of IGF-I was decreased in fibroblasts from two patients with a chromosomal deletion, but no clear impairment in biological response to IGF-I was found.
IGF-I receptor messenger ribonucleic acid levels were 45% and 52% of control values.
C
grade
Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system.
IGF-1 LR3 (Long R3 IGF-1) · The Journal of clinical endocrinology and metabolism · 1997 · ObservationalHigh-impact journal
Keratinocytes can produce a protease that affects IGFBP-3, and IGF-I may protect IGFBP-3 from degradation, but the clinical implications of these findings are unclear.
Not reported in abstract.
C
grade
Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells.
IGF-1 LR3 (Long R3 IGF-1) · The Journal of clinical endocrinology and metabolism · 2003 · ObservationalHigh-impact journal
IGF-I significantly stimulates telomerase activity in prostate cancer cells, but these findings are based on in vitro studies and require further investigation in human models.
IGF-I stimulated baseline telomerase activity in all three cell lines, ranging from 2- to 10-fold (P < 0.05).
B
grade
Long-anchoring Stent Method as a Rescue Technique for Early Dysfunction of Covered Self-Expandable Metal Stents in Distal Malignant Biliary Obstruction: A Retrospective Case Series.
IGF-1 LR3 (Long R3 IGF-1) · DEN open · 2023 · Observational · n=15
The long-anchoring stent method appears to be a safe and effective approach for managing early dysfunction of covered SEMS in patients with distal malignant biliary obstruction.
Median angle of the SEMS significantly straightened from 128.3° to 151.5° after anchoring stent placement, p < 0.001.
B
grade
Ulcerative Esophagitis With Marked Eosinophilic Infiltration and Fluorodeoxyglucose-Positron Emission Tomography Positivity Requiring Differentiation From Esophagogastric Junction Carcinoma.
IGF-1 LR3 (Long R3 IGF-1) · DEN open · 2023 · Case report · n=1
Eosinophilic esophagitis can present with ulceration and stricture, requiring careful differentiation from esophageal cancer. Mucosal healing can occur with appropriate treatment, including proton pump inhibitors.
70 eosinophils per high-power field in biopsy specimens.
B
grade
Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.
IGF-1 LR3 (Long R3 IGF-1) · The Annals of thoracic surgery · 2026 · Observational
Reoperative surgical mitral valve replacement may provide better long-term survival compared to transcatheter mitral valve-in-valve replacement in patients with failing bioprosthetic valves, but treatment decisions should consider both short-term risks and long-term benefits.
20.3% mortality for rSMVR vs 40.9% for mViV at 5 years, P = .01
C
grade
Zein-Derived Peptides from Corn Promote the Proliferation of C<sub>2</sub>C<sub>12</sub> Myoblasts via Crosstalk of mTORC1 and mTORC2 Signaling Pathways.
IGF-1 LR3 (Long R3 IGF-1) · europepmc · 2024 · Observational · Preclinical
Zein-derived peptides increased C2C12 myoblast cell viability by 33.37 to 42.39% and reduced apoptosis from 34.08% to 28.96%, but these findings are based on in vitro studies.
Cell viability increased by 33.37 to 42.39% with zein peptides at 0.05-0.2 mg/mL.
Showing 17 of 17